Ausgabe 1/2006
Inhalt (14 Artikel)
The role of postprandial hyperglycemia and hyperlipidemia in CVD risk
Robert J. Heine
The renin-angiotensin system and its blockade in diabetic renal and cardiovascular disease
Kambiz Kalantarinia, Mark D. Okusa
The safety and efficacy of statin therapy: An expanding database
Eugene J. Barrett
The PROactive study: Pioglitazone in the secondary prevention of macrovascular events in patients with type 2 diabetes
Richard E. Pratley
Impaired fibrinolysis and risk for cardiovascular disease in the metabolic syndrome and type 2 diabetes
Susanne Trost, Richard E. Pratley, Burton E. Sobel
Low-carbohydrate or low-fat diets for the metabolic syndrome?
Michael L. Dansinger, Ernst J. Schaefer
Metabolic syndrome in the elderly
Matthew Bechtold, John Palmer, Joshua Valtos, Catherine Iasiello, James Sowers
Should all patients with metabolic syndrome be treated with statins?
Nicola Abate, Manisha Chandalia
Risk of T2DM and impaired fasting glucose among pcos subjects: Results of an 8-year follow-up
Monique Y. Boudreaux, Evelyn O. Talbott, Kevin E. Kip, Maria M. Brooks, Selma F. Witchel